{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T14:45:51Z","timestamp":1779893151676,"version":"3.53.1"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T00:00:00Z","timestamp":1747958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T00:00:00Z","timestamp":1747958400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004722","name":"Stiftelsen Lars Hiertas Minne","doi-asserted-by":"publisher","award":["FO2023-0253"],"award-info":[{"award-number":["FO2023-0253"]}],"id":[{"id":"10.13039\/501100004722","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003170","name":"Stiftelsen f\u00f6r Kunskaps- och Kompetensutveckling","doi-asserted-by":"publisher","award":["20200063"],"award-info":[{"award-number":["20200063"]}],"id":[{"id":"10.13039\/501100003170","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Viruses"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Tick-borne encephalitis (TBE) is one of the most important tick-transmitted diseases in Europe and Asia. With no specific antiviral treatment available, vaccination remains the most effective protective strategy for TBE. Unlike currently available inactivated TBE vaccines that require repeated boosters, live-attenuated vaccines could offer lifelong immunity with a single dose. Langat virus (LGTV) is a naturally attenuated strain of TBE virus (TBEV). In this study, we engineered and rescued four infectious clones (ICs) of LGTV using RNA- and DNA-based reverse genetics methods. The ICs rescued by DNA-based method showed higher genetic stability in cell culture. One of the ICs rescued by DNA-based method was further evaluated in vitro and in vivo, which exhibited growth kinetics and immune profile comparable to the LGTV strain in our laboratory. This reverse genetics platform will be utilized to introduce targeted mutations within the LGTV genome to develop a live-attenuated TBE vaccine.<\/jats:p>","DOI":"10.1038\/s44298-025-00129-6","type":"journal-article","created":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T10:05:37Z","timestamp":1747994737000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Development of Langat virus infectious clones as a platform for live-attenuated tick-borne encephalitis vaccine"],"prefix":"10.1038","volume":"3","author":[{"given":"Naveed","family":"Asghar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita","family":"Jaafar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Valko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivia","family":"Merinder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl","family":"Ljungberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carl M\u00e5rten","family":"Lindqvist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magnus","family":"Johansson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,23]]},"reference":[{"key":"129_CR1","doi-asserted-by":"publisher","first-page":"6603","DOI":"10.3390\/jcm12206603","volume":"12","author":"M Kwasnik","year":"2023","unstructured":"Kwasnik, M., Rola, J. & Rozek, W. Tick-borne encephalitis-review of the current status. J. Clin. Med. 12, 6603 (2023).","journal-title":"J. Clin. Med."},{"key":"129_CR2","doi-asserted-by":"publisher","first-page":"102388","DOI":"10.1016\/j.ttbdis.2024.102388","volume":"15","author":"FJ Angulo","year":"2024","unstructured":"Angulo, F. J. et al. Publicly available surveillance data on tick-borne encephalitis in Europe, 2023. Ticks Tick. Borne Dis. 15, 102388 (2024).","journal-title":"Ticks Tick. Borne Dis."},{"key":"129_CR3","doi-asserted-by":"crossref","first-page":"2200543","DOI":"10.2807\/1560-7917.ES.2023.28.11.2200543","volume":"28","author":"J Van Heuverswyn","year":"2023","unstructured":"Van Heuverswyn, J. et al. Spatiotemporal spread of tick-borne encephalitis in the EU\/EEA, 2012 to 2020. Eur. Surveill. 28, 2200543 (2023).","journal-title":"Eur. Surveill."},{"key":"129_CR4","doi-asserted-by":"publisher","first-page":"451","DOI":"10.3390\/vaccines8030451","volume":"8","author":"M Kubinski","year":"2020","unstructured":"Kubinski, M. et al. Tick-borne Encephalitis virus: a quest for better vaccines against a virus on the rise. Vaccines 8, 451 (2020).","journal-title":"Vaccines"},{"key":"129_CR5","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1093\/cid\/ciz176","volume":"70","author":"KE Hansson","year":"2020","unstructured":"Hansson, K. E. et al. Tick-borne Encephalitis vaccine failures: a 10-year retrospective study supporting the rationale for adding an extra priming dose in individuals starting at age 50 years. Clin. Infect. Dis. 70, 245\u2013251 (2020).","journal-title":"Clin. Infect. Dis."},{"key":"129_CR6","doi-asserted-by":"publisher","first-page":"860","DOI":"10.3390\/v15040860","volume":"15","author":"SK Dutta","year":"2023","unstructured":"Dutta, S. K. & Langenburg, T. A perspective on current flavivirus vaccine development: a brief review. Viruses 15, 860 (2023).","journal-title":"Viruses"},{"key":"129_CR7","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/S0166-3542(02)00206-1","volume":"57","author":"TS Gritsun","year":"2003","unstructured":"Gritsun, T. S., Lashkevich, V. A. & Gould, E. A. Tick-borne encephalitis. Antivir. Res. 57, 129\u2013146 (2003).","journal-title":"Antivir. Res."},{"key":"129_CR8","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.antiviral.2019.01.014","volume":"164","author":"D Ruzek","year":"2019","unstructured":"Ruzek, D. et al. Tick-borne encephalitis in Europe and Russia: review of pathogenesis, clinical features, therapy, and vaccines. Antivir. Res. 164, 23\u201351 (2019).","journal-title":"Antivir. Res."},{"key":"129_CR9","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1006\/viro.2000.0426","volume":"274","author":"AG Pletnev","year":"2000","unstructured":"Pletnev, A. G. et al. Chimeric Langat\/Dengue viruses protect mice from heterologous challenge with the highly virulent strains of tick-borne encephalitis virus. Virology 274, 26\u201331 (2000).","journal-title":"Virology"},{"key":"129_CR10","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1128\/JVI.80.3.1427-1439.2006","volume":"80","author":"AA Rumyantsev","year":"2006","unstructured":"Rumyantsev, A. A., Murphy, B. R. & Pletnev, A. G. A tick-borne Langat virus mutant that is temperature sensitive and host range restricted in neuroblastoma cells and lacks neuroinvasiveness for immunodeficient mice. J. Virol. 80, 1427\u20131439 (2006).","journal-title":"J. Virol."},{"key":"129_CR11","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1093\/oxfordjournals.aje.a120633","volume":"84","author":"IS Thind","year":"1966","unstructured":"Thind, I. S. & Price, W. H. A chick embryo attenuated strain (TP21 E5) of Langat virus. I. Virulence of the virus for mice and monkeys. Am. J. Epidemiol. 84, 193\u2013213 (1966).","journal-title":"Am. J. Epidemiol."},{"key":"129_CR12","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-020-01943-w","volume":"17","author":"R Lindqvist","year":"2020","unstructured":"Lindqvist, R. et al. The envelope protein of tick-borne encephalitis virus influences neuron entry, pathogenicity, and vaccine protection. J. Neuroinflamm. 17, 284 (2020).","journal-title":"J. Neuroinflamm."},{"key":"129_CR13","doi-asserted-by":"publisher","first-page":"2462","DOI":"10.1099\/vir.0.068023-0","volume":"95","author":"F Aubry","year":"2014","unstructured":"Aubry, F. et al. Single-stranded positive-sense RNA viruses generated in days using infectious subgenomic amplicons. J. Gen. Virol. 95, 2462\u20132467 (2014).","journal-title":"J. Gen. Virol."},{"key":"129_CR14","doi-asserted-by":"publisher","first-page":"20","DOI":"10.3390\/ijms18010020","volume":"18","author":"A Nogales","year":"2016","unstructured":"Nogales, A. & Martinez-Sobrido, L. Reverse genetics approaches for the development of influenza vaccines. Int. J. Mol. Sci. 18, 20 (2016).","journal-title":"Int. J. Mol. Sci."},{"key":"129_CR15","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1016\/j.chom.2020.04.003","volume":"27","author":"MT Yeh","year":"2020","unstructured":"Yeh, M. T. et al. Engineering the live-attenuated polio vaccine to prevent reversion to virulence. Cell Host Microbe 27, 736\u2013751.e8 (2020).","journal-title":"Cell Host Microbe"},{"key":"129_CR16","doi-asserted-by":"publisher","first-page":"73","DOI":"10.3390\/vaccines6040073","volume":"6","author":"G Li","year":"2018","unstructured":"Li, G., Teleki, C. & Wang, T. Memory T cells in flavivirus vaccination. Vaccines 6, 73 (2018).","journal-title":"Vaccines"},{"key":"129_CR17","doi-asserted-by":"publisher","first-page":"813","DOI":"10.3390\/v15040813","volume":"15","author":"B Wu","year":"2023","unstructured":"Wu, B., Qi, Z. & Qian, X. Recent advancements in mosquito-borne flavivirus vaccine development. Viruses 15, 813 (2023).","journal-title":"Viruses"},{"key":"129_CR18","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1099\/vir.0.011437-0","volume":"90","author":"KL Mansfield","year":"2009","unstructured":"Mansfield, K. L. et al. Tick-borne encephalitis virus - a review of an emerging zoonosis. J. Gen. Virol. 90, 1781\u20131794 (2009).","journal-title":"J. Gen. Virol."},{"key":"129_CR19","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.antiviral.2014.12.007","volume":"114","author":"F Aubry","year":"2015","unstructured":"Aubry, F. et al. Flavivirus reverse genetic systems, construction techniques and applications: a historical perspective. Antivir. Res. 114, 67\u201385 (2015).","journal-title":"Antivir. Res."},{"key":"129_CR20","doi-asserted-by":"publisher","first-page":"2927","DOI":"10.1128\/JVI.01986-10","volume":"85","author":"SY Pu","year":"2011","unstructured":"Pu, S. Y. et al. Successful propagation of flavivirus infectious cDNAs by a novel method to reduce the cryptic bacterial promoter activity of virus genomes. J. Virol. 85, 2927\u20132941 (2011).","journal-title":"J. Virol."},{"key":"129_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/srep39265","volume":"6","author":"N Asghar","year":"2016","unstructured":"Asghar, N. et al. The role of the poly(A) tract in the replication and virulence of tick-borne encephalitis virus. Sci. Rep. 6, 39265 (2016).","journal-title":"Sci. Rep."},{"key":"129_CR22","doi-asserted-by":"publisher","first-page":"902","DOI":"10.3390\/v12080902","volume":"12","author":"R Helmova","year":"2020","unstructured":"Helmova, R. et al. Tick-borne Encephalitis virus adaptation in different host environments and existence of quasispecies. Viruses 12, 902 (2020).","journal-title":"Viruses"},{"key":"129_CR23","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1099\/jgv.0.001003","volume":"99","author":"AG Litov","year":"2018","unstructured":"Litov, A. G. et al. Evaluation of the population heterogeneity of TBEV laboratory variants using high-throughput sequencing. J. Gen. Virol. 99, 240\u2013245 (2018).","journal-title":"J. Gen. Virol."},{"key":"129_CR24","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1099\/0022-1317-43-1-247","volume":"43","author":"JM Emeny","year":"1979","unstructured":"Emeny, J. M. & Morgan, M. J. Regulation of the interferon system - evidence that vero cells have a genetic defect in interferon-production. J. Gen. Virol. 43, 247\u2013252 (1979).","journal-title":"J. Gen. Virol."},{"key":"129_CR25","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.virol.2016.03.006","volume":"493","author":"E Frumence","year":"2016","unstructured":"Frumence, E. et al. The South Pacific epidemic strain of Zika virus replicates efficiently in human epithelial A549 cells leading to IFN-beta production and apoptosis induction. Virology 493, 217\u2013226 (2016).","journal-title":"Virology"},{"key":"129_CR26","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1038\/nbt.1635","volume":"28","author":"AS Lauring","year":"2010","unstructured":"Lauring, A. S., Jones, J. O. & Andino, R. Rationalizing the development of live attenuated virus vaccines. Nat. Biotechnol. 28, 573\u2013579 (2010).","journal-title":"Nat. Biotechnol."},{"key":"129_CR27","doi-asserted-by":"publisher","first-page":"2074","DOI":"10.1002\/eji.202149181","volume":"51","author":"L Nouveau","year":"2021","unstructured":"Nouveau, L. et al. Immunological analysis of the murine anti-CD3-induced cytokine release syndrome model and therapeutic efficacy of anti-cytokine antibodies. Eur. J. Immunol. 51, 2074\u20132085 (2021).","journal-title":"Eur. J. Immunol."},{"key":"129_CR28","doi-asserted-by":"publisher","first-page":"93","DOI":"10.3390\/vaccines7030093","volume":"7","author":"L Li","year":"2019","unstructured":"Li, L. et al. Attenuation of Zika virus by passage in human hela cells. Vaccines 7, 93 (2019).","journal-title":"Vaccines"},{"key":"129_CR29","doi-asserted-by":"publisher","first-page":"e00889","DOI":"10.1128\/JVI.00889-20","volume":"94","author":"TK Resch","year":"2020","unstructured":"Resch, T. K. et al. Serial passaging of the human rotavirus CDC-9 strain in cell culture leads to attenuation: characterization from in vitro and in vivo studies. J. Virol. 94, e00889\u201320 (2020).","journal-title":"J. Virol."},{"key":"129_CR30","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.00645-24","volume":"98","author":"L Zhang","year":"2024","unstructured":"Zhang, L. et al. Serial cell culture passaging in vitro led to complete attenuation and changes in the characteristic features of a virulent porcine deltacoronavirus strain. J. Virol. 98, e0064524 (2024).","journal-title":"J. Virol."},{"key":"129_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-019-0132-6","volume":"4","author":"C Herv\u00e9","year":"2019","unstructured":"Herv\u00e9, C. et al. The how\u2019s and what\u2019s of vaccine reactogenicity. Npj Vaccines 4, 39 (2019).","journal-title":"Npj Vaccines"},{"key":"129_CR32","doi-asserted-by":"publisher","first-page":"849313","DOI":"10.3389\/fmicb.2022.849313","volume":"13","author":"W Ahmed","year":"2022","unstructured":"Ahmed, W. et al. An experimental murine model to study acquisition dynamics of tick-borne langat virus in ixodes scapularis. Front. Microbiol. 13, 849313 (2022).","journal-title":"Front. Microbiol."},{"key":"129_CR33","doi-asserted-by":"publisher","first-page":"5951","DOI":"10.1016\/j.vaccine.2017.03.032","volume":"35","author":"ADT Barrett","year":"2017","unstructured":"Barrett, A. D. T. Yellow fever live attenuated vaccine: a very successful live attenuated vaccine but still we have problems controlling the disease. Vaccine 35, 5951\u20135955 (2017).","journal-title":"Vaccine"},{"key":"129_CR34","doi-asserted-by":"publisher","first-page":"2436","DOI":"10.1128\/JVI.02273-08","volume":"83","author":"M Lobigs","year":"2009","unstructured":"Lobigs, M. et al. Live chimeric and inactivated japanese Encephalitis virus vaccines differ in their cross-protective values against murray valley Encephalitis virus. J. Virol. 83, 2436\u20132445 (2009).","journal-title":"J. Virol."},{"key":"129_CR35","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1093\/cid\/ciab864","volume":"75","author":"L Rivera","year":"2022","unstructured":"Rivera, L. et al. Three-year efficacy and safety of Takeda\u2019s Dengue vaccine candidate (TAK-003). Clin. Infect. Dis. 75, 107\u2013117 (2022).","journal-title":"Clin. Infect. Dis."},{"key":"129_CR36","doi-asserted-by":"publisher","first-page":"1134371","DOI":"10.3389\/fimmu.2023.1134371","volume":"14","author":"M Kubinski","year":"2023","unstructured":"Kubinski, M. et al. Cross-reactive antibodies against Langat virus protect mice from lethal tick-borne encephalitis virus infection. Front. Immunol. 14, 1134371 (2023).","journal-title":"Front. Immunol."},{"key":"129_CR37","doi-asserted-by":"publisher","first-page":"196","DOI":"10.3390\/vaccines9030196","volume":"9","author":"M Petry","year":"2021","unstructured":"Petry, M. et al. Immunity to TBEV related flaviviruses with reduced pathogenicity protects mice from disease but not from TBEV entry into the CNS. Vaccines 9, 196 (2021).","journal-title":"Vaccines"},{"key":"129_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.virol.2008.11.023","volume":"384","author":"D Ruzek","year":"2009","unstructured":"Ruzek, D. et al. CD8+ T-cells mediate immunopathology in tick-borne encephalitis. Virology 384, 1\u20136 (2009).","journal-title":"Virology"},{"key":"129_CR39","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1038\/178581a0","volume":"178","author":"CE Smith","year":"1956","unstructured":"Smith, C. E. A virus resembling Russian spring-summer encephalitis virus from an ixodid tick in Malaya. Nature 178, 581\u2013582 (1956).","journal-title":"Nature"},{"key":"129_CR40","doi-asserted-by":"crossref","unstructured":"Bolger, A. M., Lohse, M. & Usadel, B. Trimmomatic: a flexible trimmer for Illumina sequence data. Bioinformatics. 30, 2114\u20132120 (2014).","DOI":"10.1093\/bioinformatics\/btu170"},{"key":"129_CR41","doi-asserted-by":"crossref","unstructured":"Li, H. & Durbin, R. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics. 25, 1754\u20131760 (2009).","DOI":"10.1093\/bioinformatics\/btp324"},{"key":"129_CR42","doi-asserted-by":"crossref","unstructured":"Wilm, A. et al. LoFreq: a sequence-quality aware, ultra-sensitive variant caller for uncovering cell-population heterogeneity from high-throughput sequencing datasets. Nucleic Acids Res. 40, 11189\u201311201 (2012).","DOI":"10.1093\/nar\/gks918"},{"key":"129_CR43","doi-asserted-by":"crossref","unstructured":"Berglund, E. C. et al. Accurate detection of subclonal single nucleotide variants in whole genome amplified and pooled cancer samples using HaloPlex target enrichment. BMC Genomics. 14, 856 (2013).","DOI":"10.1186\/1471-2164-14-856"},{"key":"129_CR44","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.3390\/v13071198","volume":"13","author":"PT Tran","year":"2021","unstructured":"Tran, P. T. et al. Roles of the endogenous lunapark protein during flavivirus replication. Viruses 13, 1198 (2021).","journal-title":"Viruses"},{"key":"129_CR45","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-29075-0","volume":"13","author":"TE Hoornweg","year":"2023","unstructured":"Hoornweg, T. E. et al. Rescue and in vitro characterization of a divergent TBEV-Eu strain from the Netherlands. Sci. Rep. 13, 2872 (2023).","journal-title":"Sci. Rep."}],"container-title":["npj Viruses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s44298-025-00129-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s44298-025-00129-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s44298-025-00129-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T12:05:06Z","timestamp":1748001906000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s44298-025-00129-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,23]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["129"],"URL":"https:\/\/doi.org\/10.1038\/s44298-025-00129-6","relation":{},"ISSN":["2948-1767"],"issn-type":[{"value":"2948-1767","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,23]]},"assertion":[{"value":"21 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"44"}}